Skip to main content

Campylobacter Species

  • Chapter
  • 936 Accesses

Part of the book series: Infectious Disease™ ((ID))

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. 1. Allos BM. Campylobacter jejuni infections: Update on emerging issues and trends. Clin Infect Dis. 2001; 32:1201–1206.

    Article  PubMed  CAS  Google Scholar 

  2. 2. Karmali MA, Fleming PC. Campylobacter enteritis in children. J Pediatr. 1979; 94:527–533.

    Article  PubMed  CAS  Google Scholar 

  3. 3. Rees JH, Soudain SE, Gregson NA, Hughes RAC. Campylobacter jejuni infection and Guillain-Barré syndrome. N Engl J Med. 1995; 333:1374–1379.

    Article  PubMed  CAS  Google Scholar 

  4. 4. McCarthy N, Giesecke J. Incidence of Guillain-Barré syndrome following infection with Campylobacter jejuni. Am J Epidemiol. 2001; 153:610–614.

    Article  PubMed  CAS  Google Scholar 

  5. 5. Aspinall GO, Fujimoto S, McDonald AG, Pang H, et al. Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barré syndrome patients mimic human gangliosides in structure. Infect Immun. 1994; 62:2122–2125.

    PubMed  CAS  Google Scholar 

  6. 6. Sheikh KA, Nachamkin I, Ho TW, Willison HJ, et al. Campylobacter jejuni lipopolysaccharides in Guillain-Barré syndrome: molecular mimicry and host susceptibility. Neurol. 1998; 51:371–378.

    CAS  Google Scholar 

  7. 7. Yuki, N, Ichikawa, H, Doi A. Fisher syndrome after Campylobacter jejuni enteritis: human leukocyte antigen and the bacterial serotype. J Pediatr. 1995; 126:55–57.

    Article  PubMed  CAS  Google Scholar 

  8. 8. Jacobs BC, Hazenberg MP, van Doorn PA, Endtz HP, van der Meche FG. Cross-reacting antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in patients with Guillain-Barré or Miller-Fisher syndrome. J Infect Dis. 1997; 175:729–733.

    PubMed  CAS  Google Scholar 

  9. 9. Shahar E, Shorer Z, Roifman CM, Levi Y, et al. Immune globulins are effective in treatment of severe pediatric Guillain-Barré syndrome. Pediatr Neurol. 1997; 16:32

    Article  PubMed  CAS  Google Scholar 

  10. 10. Khatri BO, Flamini JR, Baruah JK, Dobyns WB, Konkol RJ. Plasmapheresis with acute inflammatory polyneuropathy. Pediatr Neurol. 1990; 6:17–19.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Humana Press, a part of Springer Science + Business Media, LLC

About this chapter

Cite this chapter

Stechenberg, B. (2008). Campylobacter Species. In: The Neurological Manifestations of Pediatric Infectious Diseases and Immunodeficiency Syndromes. Infectious Disease™. Humana Press. https://doi.org/10.1007/978-1-59745-391-2_18

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-391-2_18

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-967-3

  • Online ISBN: 978-1-59745-391-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics